All women N = 325 | Low risk N = 60 | Average risk N = 125 | Moderate risk N = 80 | High risk N = 60 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Age (years), mean (SD)a | 61.3 | (4.9) | 61.9 | (4.7) | 61.5 | (5.1) | 61.8 | (4.9) | 60.0 | (4.6) |
Education level, n (%)b | ||||||||||
Lower education | 68 | (20.9) | 14 | (23.3) | 27 | (21.6) | 14 | (17.5) | 13 | (21.7) |
Higher secondary education | 98 | (30.2) | 13 | (21.7) | 42 | (33.6) | 26 | (32.5) | 17 | (28.3) |
Higher vocational qualification | 131 | (40.3) | 24 | (40.0) | 46 | (36.8) | 37 | (46.3) | 24 | (40.0) |
Marital status, n living with partner (%) | 256 | (78.8) | 54 | (90.0) | 94 | (75.2) | 61 | (76.3) | 47 | (78.3) |
First degree family history breast cancer, n yes (%) | 138 | (42.5) | 4 | (6.7) | 41 | (32.8) | 49 | (61.3) | 44 | (73.3) |
Body mass index (kg/m2), mean (SD)c | 24.9 | (3.5) | 25.1 | (3.3) | 24.7 | (3.5) | 24.8 | (3.4) | 25.3 | (3.8) |
Medical condition, n ≥ 2 diagnosed (%) | 164 | (50.5) | 27 | (45.0) | 68 | (54.4) | 47 | (58.8) | 22 | (36.7) |
Current medication use, n yes (%) | 144 | (44.3) | 30 | (50.0) | 56 | (44.8) | 33 | (41.3) | 25 | (41.7) |
Current MHTd use, n yes (%) | 26 | (8.0) | 8 | (13.3) | 14 | (11.2) | 4 | (5.0) | 20 | (33.3) |
Benign breast disease, n yes (%)e | 121 | (37.2) | 21 | (35.0) | 41 | (32.8) | 35 | (43.8) | 24 | (40.0) |
Previous breast biopsy, n yes (%)f | 81 | (24.9) | 10 | (16.7) | 30 | (24.0) | 21 | (26.3) | 20 | (33.3) |
General health score, mean (SD) | 82.7 | (14.6) | 84.1 | (17.5) | 81.3 | (15.0) | 84.4 | (11.9) | 81.7 | (14.2) |
Life events, n ≥ 2 (%) | 89 | (27.4) | 15 | (25.0) | 34 | (27.2) | 24 | (30.0) | 16 | (26.7) |
Health locus of controlg, n (%) | ||||||||||
Internal | 109 | (33.5) | 21 | (35.0) | 44 | (35.2) | 23 | (28.7) | 21 | (35.0) |
Physician | 11 | (3.4) | 2 | (3.3) | 5 | (4.0) | 2 | (2.5) | 2 | (3.3) |
Chance | 167 | (51.4) | 31 | (51.7) | 61 | (48.8) | 47 | (58.8) | 28 | (46.7) |
No clear preference | 38 | (11.7) | 6 | (10.0) | 15 | (12.0) | 8 | (10.0) | 9 | (15.0) |
Belief in medicines, mean (SD) | ||||||||||
Harm | 7.9 | (2.3) | 8.5 | (2.6) | 7.8 | (2.2) | 8.0 | (2.2) | 7.3 | (2.2) |
Overuse | 11.3 | (3.0) | 11.6 | (3.0) | 11.2 | (2.8) | 11.6 | (3.2) | 10.9 | (3.0) |
Health anxiety, mean (SD) | 10.8 | (4.9) | 8.8 | (4.4) | 10.8 | (4.9) | 11.2 | (4.3) | 12.2 | (5.4) |